Clinical Trials Browser

Phase 3 × Carcinoma, Renal Cell × Thalidomide × Clear all

NCT00005966 2009-02-05

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms